[1] |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1):47-53. DOI: 10.1016/j.jncc.2024.01.006.
|
[2] |
Shao Z, Liu X, Peng C, et al. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review[J]. World J Surg Oncol, 2021, 19(1): 293. DOI: 10.1186/s12957-021-02401-4.
|
[3] |
Wu J, Wu J, Li S, et al. Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a treatment with Chinese characteristics[J]. Biosci Trends, 2024, 18(1): 42-48. DOI: 10.5582/bst.2023.01326.
|
[4] |
Zeng JT, Wang Y, Wang Y, et al. Elevated procalcitonin levels in the absence of infection in procalcitonin-secretin hepatocellular carcinoma: a case report[J]. World J Clin Cases, 2022, 10(29): 10811-10816. DOI: 10.12998/wjcc.v10.i29.10811.
|
[5] |
Ko DS, Kim SH, Park JY, et al. Milk fat globule-EGF factor 8 contributes to progression of hepatocellular carcinoma[J]. Cancers (Basel), 2020, 12(2): 403. DOI: 10.3390/cancers12020403.
|
[6] |
Marcovecchio PM, Thomas G, Salek-Ardakani S. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer[J]. J Immunother Cancer, 2021, 9(2): e002045. DOI: 10.1136/jitc-2020-002045.
|
[7] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 中国实用外科杂志, 2020, 40(2): 121-138. DOI: 10.19538/j.cjps.issn1005-2208.2020.02.01.
|
[8] |
Liu H, Yan Y, Chen R, et al. Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma[J]. Cancer Cell Int, 2020, 20: 140. DOI: 10.1186/s12935-020-01216-9.
|
[9] |
中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 现代实用医学, 2003, 15(7): 460-465. DOI: 10.3969/j.issn.1671-0800.2003.07.045.
|
[10] |
Oh CH. Transcatheter arterial chemoembolization-induced bile duct necrosis with hemobilia in hepatocellular carcinoma: endoscopic visualization and repair[J]. Endoscopy, 2021, 53(7): E265-E266. DOI: 10.1055/a-1260-2874.Epub.
|
[11] |
刘松, 于广计, 王庆东. DEBIRI-TACE联合瑞戈非尼三线以上治疗结直肠癌肝转移的疗效及影响因素分析[J]. 国际肿瘤学杂志, 2022, 49(7): 400-407. DOI: 10.3760/cma.j.cn371439-20220318-00077.
|
[12] |
Nakagomi R, Tateishi R, Mikami S, et al. Infectious complications related to radiofrequency ablation of liver tumors: the role of antibio-tics[J]. PLoS One, 2021, 16(11): e0259641. DOI: 10.1371/journal.pone.0259641.
|
[13] |
Liu KC, Lv WF, Lu D, et al. Initial experience of drug-eluting bead-transcatheter arterial chemoembolization after lipiodol-based transcatheter arterial chemoembolization failure for patients with advanced hepatocellular carcinoma[J]. Cancer Manag Res, 2021, 13: 7973-7980. DOI: 10.2147/CMAR.S332571.
|
[14] |
Das U, Anandhi A, Sureshkumar S, et al. Procalcitonin and C-reactive protein as an early predictor of infection in elective gastrointestinal cancer surgery—a prospective observational study[J]. J Gastrointest Cancer, 2022, 53(3): 605-613. DOI: 10.1007/s12029-021-00661-7.
|
[15] |
Li X, Zhang Y, Wang X, et al. Predicting infectious complications after percutaneous thermal ablation of liver malignancies: a 12-year single-center experience[J]. Radiology, 2023, 308(2): e223091. DOI: 10.1148/radiol.223091.
|
[16] |
Wymer KM, Sharma V, Manka M, et al. A serum C-reactive protein and procalcitonin-based risk score to predict urinary infection in patients with obstructive urolithiasis undergoing decompression[J]. J Endourol, 2021, 35(3): 369-375. DOI: 10.1089/end.2020.0163.
|
[17] |
饶亚华, 崔天盆. 乳脂肪球表皮生长因子8与乳腺癌相关性研究进展[J]. 微循环学杂志, 2021, 31(2): 66-69. DOI: 10.3969/j.issn.1005-1740.2021.02.014.
|
[18] |
Wu J, Yang H, Cheng J, et al. Knockdown of milk-fat globule EGF factor-8 suppresses glioma progression in GL261 glioma cells by repressing microglial M2 polarization[J]. J Cell Physiol, 2020, 235(11): 8679-8690. DOI: 10.1002/jcp.29712.
|
[19] |
Liang YK, Deng ZK, Chen MT, et al. CXCL9 is a potential biomarker of immune infiltration associated with favorable prognosis in ER-negative breast cancer[J]. Front Oncol, 2021, 11: 710286. DOI: 10.3389/fonc.2021.710286.
|
[20] |
Cheng CC, Chang YF, Ho AS, et al. Irradiation mediates IFNα and CXCL9 expression in non-small cell lung cancer to stimulate CD8+ T cells activity and migration toward tumors[J]. Biomedicines, 2021, 9(10): 1349. DOI: 10.3390/biomedicines9101349.
|
[21] |
孙丽娜, 李小艳, 宫婷, 等. 原发性肝癌TACE介入术后感染病原菌及其血清miR-200a、miR-221、IL-8、CRP 的预测价值[J]. 中华医院感染学杂志, 2024, 34(13): 2002-2006. DOI: 10.11816/cn.ni.2024-231849.
|